Correlation Between SPDR Bloomberg and Genmab AS

Can any of the company-specific risk be diversified away by investing in both SPDR Bloomberg and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SPDR Bloomberg and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SPDR Bloomberg High and Genmab AS, you can compare the effects of market volatilities on SPDR Bloomberg and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SPDR Bloomberg with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of SPDR Bloomberg and Genmab AS.

Diversification Opportunities for SPDR Bloomberg and Genmab AS

0.44

Correlation Coefficient

SPDR Bloomberg  Genmab AS

Very weak diversification

The 3 months correlation between SPDR and Genmab is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding SPDR Bloomberg High and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and SPDR Bloomberg is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SPDR Bloomberg High are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of SPDR Bloomberg i.e., SPDR Bloomberg and Genmab AS go up and down completely randomly.

Pair Corralation between SPDR Bloomberg and Genmab AS

Considering the 90-day investment horizon SPDR Bloomberg High is expected to generate 0.32 times more return on investment than Genmab AS. However, SPDR Bloomberg High is 3.09 times less risky than Genmab AS. It trades about -0.07 of its potential returns per unit of risk. Genmab AS is currently generating about -0.3 per unit of risk. If you would invest  9,433  in SPDR Bloomberg High on January 26, 2024 and sell it today you would lose (65.00) from holding SPDR Bloomberg High or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	82.61%
Values	Daily Returns

SPDR Bloomberg High  vs.  Genmab AS

SPDR Bloomberg High

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SPDR Bloomberg High are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, SPDR Bloomberg is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Genmab AS

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with SPDR Bloomberg and Genmab AS

The main advantage of trading using opposite SPDR Bloomberg and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SPDR Bloomberg position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.

The idea behind SPDR Bloomberg High and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.